Manoj P Samant

Title: Innovations of Manoj P Samant

Introduction

Manoj P Samant is a notable inventor based in Boston, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of engineered polypeptides. With a total of two patents to his name, his work focuses on enhancing the duration of action of therapeutic compounds.

Latest Patents

Samant's latest patents include "Engineered polypeptides having enhanced duration of action" and "Engineered polypeptides having enhanced duration of action with reduced immunogenicity." The first patent describes compounds that possess good duration of action, high potency, and convenient dosing regimens, including oral administration. These engineered polypeptides incorporate an albumin binding domain along with one or more biologically active polypeptides. The patent also outlines pharmaceutical compositions and methods of treatment for various diseases and disorders, including obesity, diabetes, Alzheimer's disease, and cardiovascular disease. The second patent similarly focuses on engineered polypeptides that offer reduced immunogenicity while maintaining effective therapeutic properties.

Career Highlights

Throughout his career, Samant has worked with prominent companies in the pharmaceutical industry, including Amylin Pharmaceuticals, Inc. and AstraZeneca Pharmaceuticals LP. His experience in these organizations has contributed to his expertise in drug development and innovation.

Collaborations

Some of his notable coworkers include Mary Erickson and David C Litzinger, who have collaborated with him on various projects in the field of biotechnology.

Conclusion

Manoj P Samant's contributions to the field of engineered polypeptides highlight his innovative approach to addressing complex medical challenges. His patents reflect a commitment to improving therapeutic options for patients with various health conditions.